| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 101 | Purification of organometallic compound | JP2006311645 | 2006-11-17 | JP2007137883A | 2007-06-07 | SHENAI-KHATKHATE DEODATTA V; DICARLO RONALD L JR |
| PROBLEM TO BE SOLVED: To provide a method for purifying an organometallic compound in respect to field of purification of the organometallic compound, particularly a material used in the vapor deposition of metal-containing films. SOLUTION: The present invention provides a method for purifying the organometallic compound by heating the organometallic compound in the presence of a trialkyl aluminum compound and a catalyst. COPYRIGHT: (C)2007,JPO&INPIT | ||||||
| 102 | Organic ammonium tungstate and molybdate compounds, and methods of preparing such compounds | JP2006501264 | 2004-04-08 | JP2006524191A | 2006-10-26 | ジェイ． ティニック ロバート |
| 新規な有機アンモニウム化合物であって、潤滑組成物の耐磨耗および減摩性状を改良する添加剤として有用である化合物を提供している。 この化合物は、金属酸水和物を１種または複数のアルキルアミンと反応させるステップにより生成される。 具体例は、タングステン酸ジトリデシルアンモニウム、タングステン酸ジ−ｎ−オクチルアンモニウム、およびモリブデン酸ジトリデシルアンモニウムの調製である | ||||||
| 103 | 有機テルル化合物、その製造方法、リビングラジカル重合開始剤、それを用いるポリマーの製造方法及びポリマー | JP2004527297 | 2002-08-06 | JPWO2004014848A1 | 2005-12-02 | 茂 山子; 吉田 潤一; 潤一 吉田 |
| 式(1)で表される有機テルル化合物はリビングラジカル重合開始剤として有用で、温和な条件下で、精密な分子量及び分子量分布制御を可能とする。〔式中、R1は、C1〜C8のアルキル基を示す。R2及びR3は、水素原子又はC1〜C8のアルキル基を示す。R4は、アリール基、置換アリール基、芳香族ヘテロ環基、オキシカルボニル基又はシアノ基を示す。〕 | ||||||
| 104 | Method for producing organotellurium compound | JP2003121825 | 2003-04-25 | JP2004323437A | 2004-11-18 | YAMAKO SHIGERU; YOSHIDA JUNICHI; KAMESHIMA TAKASHI |
| PROBLEM TO BE SOLVED: To provide a new method for producing an organotellurium compound, for example, useful as a living radical polymerization initiator. SOLUTION: The method for producing the organotellurium compound comprises reacting an azo-based polymerization initiator with a compound represented by formula (1): R 1Te-TeR 2---(1) (wherein, R 1 and R 2 are each a 1-8C alkyl group, an aryl group, a substituted aryl group or an aromatic heterocyclic group). COPYRIGHT: (C)2005,JPO&NCIPI | ||||||
| 105 | Organic metallic compound | JP2004099110 | 2004-03-30 | JP2004308007A | 2004-11-04 | SHENAI-KHATKHATE DEODATTA V; POWER MICHAEL BRENDAN |
| PROBLEM TO BE SOLVED: To provide a specific organic metallic compound suitable for use relating to a field of organic metallic compounds in general, more particularly in a vapor deposition process. SOLUTION: The organic metallic compound suitable for use as a vapor deposition precursor for a group IV metal-containing film is provided. A method of depositing the group IV metal-containing film using a certain organic metal precursor is also provided. The group IV metal-containing film is particularly useful in the manufacture of electronic devices. COPYRIGHT: (C)2005,JPO&NCIPI | ||||||
| 106 | The analysis method of the dry immunoassay element and an immunologically reactive ligand | JP14619396 | 1996-06-07 | JP3545536B2 | 2004-07-21 | アン デカン キャロル; ルイス スノッドグラス ゲイリー; エリザベス ローガン マーガレット; デニス ベイル オーニック マーシャ; オージーン スノーク ロイ |
| A dry immunoassay analytical element for assaying a ligand, comprising a support bearing: 1. an enzyme labeled ligand or an enzyme labeled receptor zone; 2. a spreading zone; and 3. a receptor zone containing a fixed concentration of an immobilized receptor for the ligand and the labeled ligand when present and the receptor is covalently bonded to polymeric beads having a diameter in the range of 0.1 to 5 mu m; characterized in that the element contains a diaryl telluride (DAT) compound and the zones can be in the same or separate layers. | ||||||
| 107 | Novel radical Bamo dichloride telluride compound | JP10664492 | 1992-04-24 | JP2709775B2 | 1998-02-04 | 博友 佐々木; 亨 藤森 |
| 108 | Fluorine-containing chiral smectic liquid crystal | JP21646994 | 1994-08-08 | JP2705714B2 | 1998-01-28 | ピーター ヤヌリス ユージン |
| 109 | Production of dialkyl tellurium and selenium dialkyl | JP50671293 | 1992-09-29 | JPH08505358A | 1996-06-11 | コール−ハミルトン，デイビツド・ジヨン; マツクイーン，ユーアン |
| (57)【要約】 ジアルキルテルル、ジアルキルセレン、二テルル化ジアルキル及び二セレン化ジアルキルの製造方法を提供する。 本方法は、カルコゲン化ナトリウムをハロゲン化アルキルと反応させることからなり、前記反応を二相系で実施し、相移動触媒を加えることを特徴とする。 | ||||||
| 110 | Carboxy, coordination complexes consisting of carboalkoxy and carbamyl substituted isonitrile radionuclides | JP20357386 | 1986-08-29 | JP2504750B2 | 1996-06-05 | ARAN JII JOONZU; ARAN DEEUISON; JEEMUZU KURONAAJI; MAIKERU JEI EIBURAMUSU |
| 111 | Fluorine-containing chiral smectic liquid crystal | JP16220587 | 1987-06-29 | JPH07116107B2 | 1995-12-13 | ピーター ヤヌリス ユージン |
| 112 | Fluorine-containing chiral smectic liquid crystal | JP21646994 | 1994-08-08 | JPH07324051A | 1995-12-12 | YUUJIN PIITAA YANURISU |
| PURPOSE: To obtain a new compound useful as an intermediate for chiral smectic liqiud crystal compounds optically active and exhibiting ferroelectric behavior. CONSTITUTION: This new compound is shown by formula I or formula II ((x) is 4-20), e.g. S-4-(4-methylhexyloxy)benzoic acid. The compound of formula I is obtained by coupling reaction between a compound of formula III and a compound of formula IV (X, Y and Z are each H, Cl, F, CH 3, OH, Br or the like; (l), (m) and (n) are each 0-4; (a), (b) and (c) are each 0-3; A is CH=N, CH 2-O, C≡C or the like; B' and B" are each OH, COOH, SH or the like; M, N and P are each cyclohexane ring or the like; R is C 9H 29-X or the like; X is H or F). This new compound is especially useful in surface-stabilized ferroelectric liquid crystal displays. COPYRIGHT: (C)1995,JPO | ||||||
| 113 | Cytokine production stimulating compound | JP25097785 | 1985-11-11 | JPH0791286B2 | 1995-10-04 | スレドニ ベンジヤミン; アルベツク マイケル |
| 114 | Kit containing coordination complex | JP29009194 | 1994-11-24 | JPH07206884A | 1995-08-08 | ARAN JII JIYOONZU; ARAN DEEBUISON; JIEEMUZU KURONAAJI; MAIKERU JIEI EIBURAMUSU |
| PURPOSE: To provide a kit for producing a coordination complex comprising a substd. isonitrile and a radionuclide and an isonitrile-containing aseptic vial. CONSTITUTION: This kit is the one for producing a coordination complex comprising an isonitrile ligand represented by the formula, (CNX)R [wherein X is a 1-4C lower alkyl group and R is selected from a group consisting of COOR 1 and CONR 2R 3 (wherein R 1 is H, a pharmacologically acceptable cation or a substd. or unsubstd. 1-4C alkyl group; and R 2 and R 3 are each H or a substd. or unsubstd. 1-4C alkyl group and same or different)] and a radionuclide selected from a group consisting of radioactive isotopes of Tc, Ru, Co, Pt and Re. An aseptic vial contains the kit comprising a predetermined amt. of a reducing agent capable of reducing a predetermined amt. of the isonitrile ligand and a predetermined amt. of the radionuclide preliminarily selected from the radioisotopes to form the complex and the isonitrile ligand. COPYRIGHT: (C)1995,JPO | ||||||
| 115 | New dicarbamoyl telluride compound | JP10664392 | 1992-04-24 | JPH05306268A | 1993-11-19 | SASAKI HIROTOMO; FUJIMORI TORU |
| PURPOSE:To provide a new compound useful as a synthetic intermediate for pharmaceuticals, agricultural chemicals, photographic chemicals, etc. CONSTITUTION:The compound of formula I (R1 and R2 are aliphatic or aromatic group), e.g. the compound of formula II. The compound of formula I can be produced e.g. by reacting a carbamoyl chloride (R1R2NCOCl) with Na2Ten (n is natural number) which is a reagent produced by reducing tellurium with sodium hydride, etc. | ||||||
| 116 | Production of oxazoles | JP26051791 | 1991-09-12 | JPH0570445A | 1993-03-23 | OGURA FUMIO; OTSUBO TETSUO; ASO YOSHIO; FUKUMOTO TAKAHIRO |
| PURPOSE:To directly obtain the subject compounds applicable to scintillators, etc., from an acetylene compound in high yield by reacting the acetylene compound with a nitrile compound using a specific organotellurium compound as a mediator. CONSTITUTION:An acetylene compound (e.g. diphenylacetylene) is reacted with a nitrile compound (e.g. acetonitrile) using an organotellurinyl compound (e.g. benzenetellurinyl trifluoroacetate) expressed by the formula (Ar is aryl or substituted aryl; R is alkyl or halogen-substituted alkyl; A is CO or SO2) as a mediator to readily afford oxazoles (e.g. 2-methyl-4,5-diphenyl-oxazole) according to intramolecular reaction without isolating an intermediate. The oxazole compounds are directly obtained from the acetylene compound in excellent regioselectivity and high yield under conditions without requiring high temperatures by the above-mentioned method. The resultant oxazole compounds are useful as scintillators, fluorescent brighteners, etc., in the field of analgesic, antiphlogistic, antimicrobial and hypotensive agents, medicines for diabetes, etc. | ||||||
| 117 | JPH03501481A - | JP50094589 | 1988-12-02 | JPH03501481A | 1991-04-04 | |
| 118 | Composition for inducing cytokine formation and method of induction | JP1596290 | 1990-01-25 | JPH02258723A | 1990-10-19 | BENJIYAMIN SUREDONI; MAIKERU ARUBETSUKU |
| PURPOSE: To obtain a composition for inducing cytokine formation by compounding a tellurium tetrahalide as an active component. CONSTITUTION: This pharmaceutical composition is composed of a tellurium tetrahalide and a pharmaceutically permissible support. The treatment of cancer, immunodeficiency, an autoimmune disease or an infectious disease is performed by using a tellurium tetrahalide as a supplemental agent or a primary treating agent. The composition stimulates cytokine formation in a living body. Further, the dose of the compound for treating said disease is 0.01-1 mg/kg-body weight, preferably 0.02-0.5mg/kg-body weight, and in the case of in vitro use, the compound in the range of 1×10<-8> to 1×10<-4> g, preferably 1×10<-7> to 1×10<-5> g is used for 10<6> cells/ml. | ||||||
| 119 | Complex of tellurium and selenium derivative | JP6341789 | 1989-03-14 | JPH0242056A | 1990-02-13 | BENJIYAMIN SUREDONII; MAIKERU ARUBETSUKU; REO PABURIFU |
| NEW MATERIAL: A complex of a compd. represented by formula I or II, or the formula; TeO 2 or the formula; phTecl 3 or formula III (wherein Q is The or Se, t, u and v are each 1 or 0, R, R 1 to R 9 are each H, a 1-5C hydroxyalkyl, hydroxy, 1-5C alkyl, halogen, 1-5C haloalkyl or carboxy and X is a halogen) and an innoxious complexing agent. USE: This new material is used in a medicine compsn. and useful as a synthetic intermediate of lymphokine and cytokine useful for treating cancer, immunity deficiency or an infection disease. PROCESS: A compd. represented by formula I or II, or the formula; TeO 2 or the formula; phTecl 3 or formula III is brought into contact with a complexing agent selected from the group consisting of a hydroxypolycarboxylic acid, polycarboxylic acid and polyhydroxypolycarboxylic acid to obtain the objective complex. COPYRIGHT: (C)1990,JPO | ||||||
| 120 | Production of 2-oxazolidinones | JP22292687 | 1987-09-08 | JPS6466176A | 1989-03-13 | OGURA FUMIO; OTSUBO TETSUO; ASO YOSHIO; KO NANSEI |
| PURPOSE:To directly obtain the titled substance in high yield and stereo- selectivity, by reacting an olefin compound with a carbamic acid ester in the presence of a Lewis acid using an organic tellurinyl compound as a mediator. CONSTITUTION:The titled substance can be produced by reacting an olefin compound with a carbamic acid ester in the presence of Lewis acid (preferably a boron trifluoride complex) using an organic tellurinyl compound as a mediator and cyclizing the addition product under mild heating (at >=70 deg.C). The reaction is preferably carried out by using chlorinated hydrocarbons as a solvent. The titled substance is useful as an intermediate for pharmaceuticals and a raw material for polymers having hydrophilic nature, polarity and specific adsorption capability. | ||||||
QQ群二维码
意见反馈
意见反馈